Cohance Lifesciences Ltd

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and with reference to ourResults conference call intimation dated May 19 2023 that audio recording of the conference call for the quarter and year ended March 31 2023 held on Friday May 262023 has been uploaded on the Companys website athttps://www.suvenpharm.com/index.php/investors/financial-info/quarterly-releaseThis is for your information and record.